We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Theranos Finds Itself in Government’s Crosshairs
More federal regulators are knocking on Theranos’ door, keen on getting answers to questions about staff qualifications and improper review of patient test results.